Real-life Follow-up of Cystic Fibrosis Patients Treated With Ivacaftor+Lumacaftor (Orkambi*)

CompletedOBSERVATIONAL

Enrollment

852

Participants

Timeline

Start Date

January 22, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions

Cystic Fibrosis

Interventions

DRUG

Ivacaftor+lumacaftor

1 year follow-up after initiation of ivacaftor+lumacaftor

Trial Locations (1)

Adult CF center, Service de Pneumologie, Cochin Hospital, Paris

All Listed Sponsors

collaborator

Effi-Stat

OTHER

collaborator

Societe Francaise de la Mucoviscidose

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT03475381 - Real-life Follow-up of Cystic Fibrosis Patients Treated With Ivacaftor+Lumacaftor (Orkambi*) | Biotech Hunter | Biotech Hunter